Clinical Trial: Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Phase II Trial of Chronic Oral ZD1839 (Iressa®) (NSC-715055) in Both Previously-Untreated and Previously-Treated Patients With Selected Stage IIIB and IV Bronchioloalveolar

Brief Summary: Phase II trial to study the effectiveness of gefitinib in treating patients who have stage IIIB or stage IV non-small cell lung cancer. Biological therapies such as gefitinib may interfere with the growth of the tumor cells and slow the growth of non-small cell lung cancer